TASHKENT, Uzbekistan, June 28. The Chamber of Commerce and Industry of Uzbekistan and Pakistan’s Glitz Group have reached an agreement to establish a joint venture in Uzbekistan focused on the production of high value-added pharmaceutical products and their export to regional markets, Trend reports.
The agreement followed a meeting between Deputy Chairman of the Chamber, Dilshod Rasulov, and Chaudhry Bilal, Director of Glitz Group—one of Pakistan’s leading international investment and pharmaceutical holdings.
During the talks, the parties discussed prospects for bilateral cooperation in the pharmaceutical, nutraceutical, and cosmeceutical sectors.
Bilal praised Uzbekistan’s rapidly growing pharmaceutical industry, highlighting the country’s favorable investment climate, ongoing reforms, and government support for foreign investors. He expressed strong interest in expanding Glitz Group’s manufacturing footprint to Uzbekistan.
In response, Rasulov endorsed the initiative and affirmed the
Chamber’s preparedness to extend comprehensive support,
encompassing facilitation of project schematics, navigation of
compliance frameworks, and establishing synergies with credible
local stakeholders.
The convening signified a pivotal advancement in the enhancement of
bilateral synergies between Uzbekistan and Pakistan within the
realms of cutting-edge technology and export-driven sectors.
Glitz Group boasts a robust portfolio of over 650 certified
offerings across its flagship brands, including Glitz Pharma, Glitz
Life Care, and Glitzderm, while strategically penetrating
international markets in over 20 countries. The organization’s
manufacturing protocols adhere to ISO and cGMP benchmarks and are
accredited by the Drug Regulatory Authority of Pakistan (DRAP).
Stay up-to-date with more news on Trend News Agency's WhatsApp channel